Royal Perth Hospital, Department of Orthopaedic Surgery, Perth, Australia.
University of Western Australia. Department of Surgery, Perth, Australia.
Am J Sports Med. 2024 Jul;52(8):1979-1983. doi: 10.1177/03635465241253266. Epub 2024 Jun 3.
Synthetic grafts have been used for a number of years in anterior cruciate ligament (ACL) reconstruction surgery. One of the more recent additions to the stable of synthetic ligaments is the Ligament Augmentation and Reconstruction System (LARS) ligament.
To analyze the biomechanics and histology of LARS grafts retrieved due to failure of the device.
Descriptive laboratory study.
A total of 22 LARS ligament grafts that were explanted from patients were sent for analysis. Five new, unused samples of the standard LARS ACL graft were also analyzed. Biomechanical testing was performed: ultimate tensile force, force versus displacement, and stress versus strain were recorded. Histopathological examination was performed looking for degree of fibrous tissue ingrowth as well as the presence of a foreign body reaction.
Of the 22 grafts retrieved, 14 were used for ACL grafts, 1 for a lateral collateral ligament graft, 2 for medial collateral ligament grafts, 4 for gluteal tendon augmentation, and 1 for a supraspinatus augmentation. A severe foreign body reaction was found in 86% of the grafts (18/22) and a mild foreign body reaction in the remaining 14% (4/22). Tissue ingrowth was minimal in the majority of ACL grafts; the other grafts showed moderate tissue ingrowth. Maximal tensile force was significantly higher for the new ACL grafts (mean ± SD, 1667 ± 845 N) compared with the retrieved grafts (897 ± 395 N; < .05).
This study demonstrated that the vast majority of retrieved LARS artificial ligaments had a florid foreign body reaction. There was minimal tissue ingrowth in ACL grafts and moderate ingrowth in other grafts. Retrieved grafts had a decreased ultimate tensile force, which increased their risk of rupture.
Surgeons should be cautious in choosing to use these grafts in reconstructive surgery for patients.
合成移植物在前交叉韧带(ACL)重建手术中已使用多年。最近加入的一种合成韧带是韧带增强和重建系统(LARS)韧带。
分析因器械失效而取出的 LARS 移植物的生物力学和组织学。
描述性实验室研究。
共分析了 22 个从患者体内取出的 LARS 韧带移植物。还分析了 5 个新的、未使用的标准 LARS ACL 移植物样本。进行了生物力学测试:记录了极限拉伸力、力与位移、应力与应变。进行了组织病理学检查,观察纤维组织内生长的程度以及异物反应的存在。
在 22 个取出的移植物中,14 个用于 ACL 移植物,1 个用于外侧副韧带移植物,2 个用于内侧副韧带移植物,4 个用于臀肌腱增强,1 个用于冈上肌腱增强。86%(18/22)的移植物有严重的异物反应,其余 14%(4/22)有轻度异物反应。大多数 ACL 移植物的组织内生长较少;其他移植物显示出中度组织内生长。新的 ACL 移植物的最大拉伸力明显高于取出的移植物(平均值±标准差,1667±845 N 比 897±395 N;<.05)。
本研究表明,大多数取出的 LARS 人工韧带都有明显的异物反应。ACL 移植物的组织内生长较少,其他移植物的组织内生长较多。取出的移植物的极限拉伸力降低,增加了它们断裂的风险。
外科医生在选择将这些移植物用于患者的重建手术时应谨慎。